📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clemastine/tamoxifen hybrids as easily accessible antileishmanial drug leads. (2024)

First Author: Agostino VS

Attributed to: A Global Network for Neglected Tropical Diseases funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d3ob02091f

PubMed Identifier: 38328995

Publication URI: http://europepmc.org/abstract/MED/38328995

Type: Journal Article/Review

Volume: 22

Parent Publication: Organic & biomolecular chemistry

Issue: 9

ISSN: 1477-0520